Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AMD1 | P17707 | 2/20 | 0.32 |
| ▸ | PI4KA | P42356 | 1/20 | 0.31 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.31 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.31 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.31 |
| ▸ | PRMT5 | O14744 | 3/20 | 0.31 |
| ▸ | WDR77 | Q9BQA1 | 3/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
| ▸ | NT5E | P21589 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31570695 | 0.93 | AMD1 (0.33) | AMD1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL31526112 | 0.91 | NT5E (0.37) | AMD1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL31526180 | 0.86 | DNMT1 (0.42) | PRMT5WDR77NT5E | |
| SCHEMBL31526328 | 0.80 | PI4KA (0.39) | AMD1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL31526226 | 0.79 | DNMT1 (0.43) | PRMT5WDR77NT5E | |
| SCHEMBL31526362 | 0.77 | NT5E (0.43) | PRMT5WDR77NT5E | |
| SCHEMBL31526378 | 0.74 | DNMT1 (0.57) | PRMT5WDR77 | |
| SCHEMBL31526133 | 0.70 | DNMT1 (0.55) | PRMT5WDR77 | |
| SCHEMBL31526113 | 0.68 | PI4KA (0.39) | AMD1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL18571691 | 0.67 | PI4KA (0.53) | PI4KAPI4K2BPI4K2API4KBPRMT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4553080-A1 | NUCLEOSIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST CORONAVIRUSES | Ustav Organicke Chemie a Biochemie AV CR, v.v.i. (CZ) | 2025-05-14 | — | — | EP | disclosed |